---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-340430"
form_type: "8-K12B"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2026-08-07T20:52:03+00:00"
generated_at: "2026-08-07T20:53:06.765128+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Wave Life Sciences completes redomiciliation to Delaware; shares trade under WVE on Nasdaq

## Summary
- On Aug 7, 2026, Wave Life Sciences, Inc. (Delaware) became parent of Wave Life Sciences Ltd. (Singapore) via scheme of arrangement; shares exchanged 1:1.
- Wave-Delaware common stock begins trading on Nasdaq under symbol WVE on Aug 10, 2026; CUSIP 94352A104; Singapore shares delisted.
- Wave-Delaware assumed all equity plans and outstanding awards; pre-funded warrants now exercisable for Wave-Delaware common stock.
- Directors and officers of Wave-Singapore became directors and officers of Wave-Delaware; indemnification agreements entered into.

## SEC filing metadata
- accession: 0001193125-26-340430
- form_type: 8-K12B
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2026-08-07T20:52:03+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 5.03, 5.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312526340430/0001193125-26-340430-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312526340430/d122282d8k12b.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-340430
- JSON: https://secwatch.observer/filing/0001193125-26-340430.json
- Plain text: https://secwatch.observer/filing/0001193125-26-340430.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.